Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

At the Research-Clinical Interface: Returning Individual Genetic Results to Research Participants.

West KM, Blacksher E, Cavanaugh KL, Fullerton SM, Umeukeje EM, Young BA, Burke W.

Clin J Am Soc Nephrol. 2020 Feb 10. pii: CJN.09670819. doi: 10.2215/CJN.09670819. [Epub ahead of print]

PMID:
32041801
2.

Incorporating patient-reported outcomes (PROs) into dialysis policy: Current initiatives, challenges, and opportunities.

Umeukeje EM, Nair D, Fissell RB, Cavanaugh KL.

Semin Dial. 2020 Jan;33(1):18-25. doi: 10.1111/sdi.12854.

PMID:
31957929
3.

Genetics and ESKD Disparities in African Americans.

Umeukeje EM, Young BA.

Am J Kidney Dis. 2019 Dec;74(6):811-821. doi: 10.1053/j.ajkd.2019.06.006. Epub 2019 Oct 10.

PMID:
31606237
4.

Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions.

Young BA, Blacksher E, Cavanaugh KL, Freedman BI, Fullerton SM, Kopp JB, Umeukeje EM, West KM, Wilson JG, Burke W; APOL1 Stakeholders Project.

Am J Nephrol. 2019;50(4):303-311. doi: 10.1159/000502675. Epub 2019 Sep 3.

PMID:
31480040
5.

Kidney Disease Awareness and Knowledge among Survivors ofAcute Kidney Injury.

Siew ED, Parr SK, Wild MG, Levea SL, Mehta KG, Umeukeje EM, Silver SA, Ikizler TA, Cavanaugh KL.

Am J Nephrol. 2019;49(6):449-459. doi: 10.1159/000499862. Epub 2019 Apr 17.

PMID:
30995659
6.

You Are Just Now Telling Us About This? African American Perspectives of Testing for Genetic Susceptibility to Kidney Disease.

Umeukeje EM, Young BA, Fullerton SM, Cavanaugh K, Owens D, Wilson JG, Burke W, Blacksher E.

J Am Soc Nephrol. 2019 Apr;30(4):526-530. doi: 10.1681/ASN.2018111091. Epub 2019 Mar 11. No abstract available.

PMID:
30858224
7.

Correction to: Health care providers' support of patients' autonomy, phosphate medication adherence, race and gender in end-stage renal disease.

Umeukeje EM, Merighi JR, Browne T, Wild M, Alsmaan H, Umanath K, Lewis JB, Wallston KA, Cavanaugh KL.

J Behav Med. 2019 Apr;42(2):376-379. doi: 10.1007/s10865-018-9992-x.

PMID:
30623275
8.

Phosphate-control adherence in hemodialysis patients: current perspectives.

Umeukeje EM, Mixon AS, Cavanaugh KL.

Patient Prefer Adherence. 2018 Jul 4;12:1175-1191. doi: 10.2147/PPA.S145648. eCollection 2018. Review.

9.

Black Americans' Perspectives of Barriers and Facilitators of Community Screening for Kidney Disease.

Umeukeje EM, Wild MG, Maripuri S, Davidson T, Rutherford M, Abdel-Kader K, Lewis J, Wilkins CH, Cavanaugh K.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):551-559. doi: 10.2215/CJN.07580717. Epub 2018 Mar 15.

10.

Health care providers' support of patients' autonomy, phosphate medication adherence, race and gender in end stage renal disease.

Umeukeje EM, Merighi JR, Browne T, Wild M, Alsmaan H, Umanath K, Lewis JB, Wallston KA, Cavanaugh KL.

J Behav Med. 2016 Dec;39(6):1104-1114. doi: 10.1007/s10865-016-9745-7. Epub 2016 May 11. Erratum in: J Behav Med. 2019 Jan 8;:.

11.

Self-Motivation Is Associated With Phosphorus Control in End-Stage Renal Disease.

Umeukeje EM, Merighi JR, Browne T, Victoroff JN, Umanath K, Lewis JB, Ikizler TA, Wallston KA, Cavanaugh K.

J Ren Nutr. 2015 Sep;25(5):433-9. doi: 10.1053/j.jrn.2015.03.001. Epub 2015 Apr 22. Erratum in: J Ren Nutr. 2019 Sep;29(5):463-464.

12.

Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.

Umanath K, Jalal DI, Greco BA, Umeukeje EM, Reisin E, Manley J, Zeig S, Negoi DG, Hiremath AN, Blumenthal SS, Sika M, Niecestro R, Koury MJ, Ma KN, Greene T, Lewis JB, Dwyer JP; Collaborative Study Group.

J Am Soc Nephrol. 2015 Oct;26(10):2578-87. doi: 10.1681/ASN.2014080842. Epub 2015 Mar 3.

Supplemental Content

Loading ...
Support Center